Pediatric Tumor
Conditions
Brief summary
DOREVI is a monocentric randomized controlled study that will evaluate the efficacy of virtual reality helmets for pain prevention during invasive care on 78 oncologic pediatric patients. Two groups of children (between 6 and 11 and between 12 and 18 years old) will be randomized to use helmet plus standard care or standard care alone during invasive procedures (central venous catheter puncture, lumbar puncture, or bone marrow aspiration). The pain intensity will be evaluated using a visual analogic scale during three invasive procedures, and results will be compared between the patients with or without virtual reality.
Interventions
OTHERVirtual reality headset
Each patient in this treatment group will use a virtual reality headset during 3 procedures. During each procedure, the pain level will be assessed and compared with the assessed group.
Sponsors
Centre Hospitalier Universitaire de la Réunion
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE
Intervention model description
intervention plus standard care versus standard care
Eligibility
Sex/Gender
ALL
Age
6 Years to 18 Years
Healthy volunteers
No
Inclusion criteria
* patient who tolerates the virtual reality headset * patient followed in pediatric oncology * patient with a diagnosis of benign tumor or cancer * patient who needs to have painful medical procedure during their treatment * patient whose parents have signed the informed consent * patient affiliated with social security or equivalent
Exclusion criteria
* patient with visual or hearing impairement * patient with epilepsy or other neurological disease * patient with psychiatric disease
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Self pain evaluation | before blood sampling on catheter with implantable chamber | Pain will be assessed by the analogic visual scale (minimal score = 0 (no pain) , maximal score = 10 (maximal pain)) |
Countries
Reunion
Contacts
CONTACTYves REGUERRE
CONTACTEmilie TECHER
PRINCIPAL_INVESTIGATORYves REGUERRE
CHU de La Réunion
Outcome results
None listed